Triple
T36599764
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | membrane-spanning 4-domains subfamily A |
E902885
|
entity |
| Predicate | hasMember |
P10
|
FINISHED |
| Object |
MS4A6A
MS4A6A is a human cell-surface protein of the MS4A family, characterized by four transmembrane domains and implicated in immune cell signaling and neurodegenerative disease risk.
|
E2190203
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: MS4A6A | Statement: [membrane-spanning 4-domains subfamily A, hasMember, MS4A6A]
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: MS4A6A Triple: [membrane-spanning 4-domains subfamily A, hasMember, MS4A6A]
Generated description
MS4A6A is a human cell-surface protein of the MS4A family, characterized by four transmembrane domains and implicated in immune cell signaling and neurodegenerative disease risk.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f76e66b7b88190848f7a3e1188915f |
completed | May 3, 2026, 3:48 p.m. |
| NER | Named-entity recognition | batch_69f7c30bc2448190b0daa9a288dec5b2 |
completed | May 3, 2026, 9:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a3d17852ae08190a60699f0066a8514 |
completed | June 25, 2026, 11:56 a.m. |
| NEDg | Description generation | batch_6a3d1828cb4081908806cc837aac45a8 |
completed | June 25, 2026, 11:59 a.m. |
| NED2 | Entity disambiguation (via description) | batch_6a3dcecff9488190829ea20f5bdde66c |
completed | June 26, 2026, 12:58 a.m. |
Created at: May 3, 2026, 4:11 p.m.